Agilent Technologies Inc (A): Today's Featured Health Services Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Agilent Technologies ( A) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day down 0.6%. By the end of trading, Agilent Technologies fell $1.36 (-2.3%) to $58.15 on average volume. Throughout the day, 3,422,847 shares of Agilent Technologies exchanged hands as compared to its average daily volume of 2,341,100 shares. The stock ranged in price between $58.05-$59.15 after having opened the day at $58.40 as compared to the previous trading day's close of $59.51. Other companies within the Health Services industry that declined today were: Hanger ( HGR), down 13.5%, American Caresource Holdings ( ANCI), down 9.5%, Pro-Dex ( PDEX), down 7.9% and Diversicare Healthcare Services ( DVCR), down 7.4%.

Agilent Technologies, Inc. provides bio-analytical and electronic measurement solutions and services to the life sciences, chemical analysis, diagnostics and genomics, communications, and electronics industries worldwide. Agilent Technologies has a market cap of $19.1 billion and is part of the health care sector. The company has a P/E ratio of 27.4, above the S&P 500 P/E ratio of 17.7. Shares are up 4.1% year to date as of the close of trading on Thursday. Currently there are 12 analysts that rate Agilent Technologies a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates Agilent Technologies as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the positive front, Accuray ( ARAY), up 15.3%, Arrhythmia Research Technology ( HRT), up 9.1%, NeuroMetrix ( NURO), up 6.4% and Novadaq Technologies ( NVDQ), up 6.3% , were all gainers within the health services industry with HCA Holdings ( HCA) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

More from Markets

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers